Could a 30-Minute face tickle ease ALS jaw pain?
NCT ID NCT07187388
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a single 30-minute session of transcutaneous electrical nerve stimulation (TENS) on the face can reduce jaw and facial pain, improve jaw movement, and make chewing easier for people with ALS or PLS. Ten participants will receive the treatment during one clinic visit and report their pain and oral hygiene difficulty 24 hours later. It is a small, early-stage trial focused on symptom relief.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Transcutaneous Electrical Nerve Stimulation (TENS) device
- What this could lead to
- If it works, this could offer a simple, non-drug way to ease facial pain and improve jaw function and oral hygiene in people with ALS or PLS.
- What could go wrong
- This is a very small, early-stage trial with only 10 participants and a single treatment session. Results may not apply to everyone, and any pain relief may be temporary.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AMYOTROPHIC LATERAL SCLEROSIS (ALS) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Nova Southeastern University, David and Cathy Husman Neuroscience Institute
RECRUITINGDavie, Florida, 33314, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a Custom-Made genetic drug slow ALS?
- Can a One-Time gene shot calm inflammation in ALS?
- Can filtering the blood slow ALS in people with a troubling antibody?
- Blood test may slash ALS diagnosis time from months to days
- Custom gene silencer takes aim at a rare form of ALS
- Could a gentle brain ZAP help ALS patients breathe easier?